These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Getting a grip on pain. A new drug may revolutionize arthritis care. Cowley G Newsweek; 1998 Dec; 132(24):66. PubMed ID: 10338868 [No Abstract] [Full Text] [Related]
44. COX-2 inhibitors. Crowther CL Lippincotts Prim Care Pract; 1999; 3(4):394-6. PubMed ID: 10624270 [No Abstract] [Full Text] [Related]
45. New reports on dental analgesics. NSAIDs and cardiovascular effects, celecoxib for dental pain, and a new analgesic--tramadol with acetaminophen. Wynn RL Gen Dent; 2002; 50(3):218-20, 22. PubMed ID: 12116507 [No Abstract] [Full Text] [Related]
53. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors. Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791 [TBL] [Abstract][Full Text] [Related]
54. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease. Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850 [No Abstract] [Full Text] [Related]
55. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective. Hochberg MC Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820 [TBL] [Abstract][Full Text] [Related]
56. Arthritis drug approved for polyp prevention blazes trail for other prevention trials. Smigel K J Natl Cancer Inst; 2000 Feb; 92(4):297-9. PubMed ID: 10675374 [No Abstract] [Full Text] [Related]
57. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice. Wolfe F; Michaud K; Burke TA; Zhao SZ J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808 [TBL] [Abstract][Full Text] [Related]